288 related articles for article (PubMed ID: 29857216)
1. The Predictive Value of Suprasellar Extension for Visual Function Evaluation in Chinese Patients with Nonfunctioning Pituitary Adenoma with Optic Chiasm Compression.
Gan L; Ma J; Feng F; Wang Y; Cui J; Guo X; Zhang X; You H; Wang Z; Yin Z; Zhong Y; Xing B
World Neurosurg; 2018 Aug; 116():e960-e967. PubMed ID: 29857216
[TBL] [Abstract][Full Text] [Related]
2. The Chiasmal Compression Index: An Integrative Assessment Tool for Visual Disturbances in Patients with Pituitary Macroadenomas.
Avraham E; Azriel A; Melamed I; Alguayn F; Al Gawad Siag A; Aloni E; Sufaro Y
World Neurosurg; 2020 Nov; 143():e44-e50. PubMed ID: 32562903
[TBL] [Abstract][Full Text] [Related]
3. Factors Affecting the Visual Outcome of Pituitary Adenoma Patients Treated with Endoscopic Transsphenoidal Surgery.
Luomaranta T; Raappana A; Saarela V; Liinamaa MJ
World Neurosurg; 2017 Sep; 105():422-431. PubMed ID: 28583452
[TBL] [Abstract][Full Text] [Related]
4. Association of retinal nerve fibre layer thickness with quantitative magnetic resonance imaging data of the optic chiasm in pituitary adenoma patients.
Glebauskiene B; Liutkeviciene R; Zlatkute E; Kriauciuniene L; Zaliuniene D
J Clin Neurosci; 2018 Apr; 50():1-6. PubMed ID: 29398198
[TBL] [Abstract][Full Text] [Related]
5. Predicting impairment of central vision from dimensions of the optic chiasm in patients with pituitary adenoma.
Carrim ZI; Reeks GA; Chohan AW; Dunn LT; Hadley DM
Acta Neurochir (Wien); 2007 Mar; 149(3):255-60; discussion 260. PubMed ID: 17273885
[TBL] [Abstract][Full Text] [Related]
6. Predictors for visual dysfunction in nonfunctioning pituitary adenomas - implications for neurosurgical management.
Schmalisch K; Milian M; Schimitzek T; Lagrèze WA; Honegger J
Clin Endocrinol (Oxf); 2012 Nov; 77(5):728-34. PubMed ID: 22747829
[TBL] [Abstract][Full Text] [Related]
7. Early morphological recovery of the optic chiasm is associated with excellent visual outcome in patients with compressive chiasmal syndrome caused by pituitary tumors.
Yoneoka Y; Hatase T; Watanabe N; Jinguji S; Okada M; Takagi M; Fujii Y
Neurol Res; 2015 Jan; 37(1):1-8. PubMed ID: 24938320
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and ophthalmologic findings of pituitary adenoma in Korean patients.
Kim TG; Jin KH; Kang J
Int Ophthalmol; 2019 Jan; 39(1):21-31. PubMed ID: 29274021
[TBL] [Abstract][Full Text] [Related]
9. Visual field defects in patients with pituitary adenomas.
Huang WC; Lee LS
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Nov; 60(5):245-51. PubMed ID: 9509679
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of secondary white matter injury in the visual pathway by pituitary adenomas: a multimodal study at 7-Tesla MRI.
Rutland JW; Padormo F; Yim CK; Yao A; Arrighi-Allisan A; Huang KH; Lin HM; Chelnis J; Delman BN; Shrivastava RK; Balchandani P
J Neurosurg; 2019 Jan; 132(2):333-342. PubMed ID: 30660127
[TBL] [Abstract][Full Text] [Related]
11. Significance and Indications of Surgery for Asymptomatic Nonfunctioning Pituitary Adenomas.
Ogiwara T; Nagm A; Nakamura T; Mbadugha T; Horiuchi T; Hongo K
World Neurosurg; 2019 Aug; 128():e752-e759. PubMed ID: 31077893
[TBL] [Abstract][Full Text] [Related]
12. Visual Defects in Patients With Pituitary Adenomas: The Myth of Bitemporal Hemianopsia.
Lee IH; Miller NR; Zan E; Tavares F; Blitz AM; Sung H; Yousem DM; Boland MV
AJR Am J Roentgenol; 2015 Nov; 205(5):W512-8. PubMed ID: 26496573
[TBL] [Abstract][Full Text] [Related]
13. Optic nerve hyperintensity on T2-weighted images among patients with pituitary macroadenoma: correlation with visual impairment.
Tokumaru AM; Sakata I; Terada H; Kosuda S; Nawashiro H; Yoshii M
AJNR Am J Neuroradiol; 2006 Feb; 27(2):250-4. PubMed ID: 16484385
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for visual recovery after transsphenoidal pituitary adenectomy.
Lee S; Kim SJ; Yu YS; Kim YH; Paek SH; Kim DG; Jung HW
Br J Neurosurg; 2013 Aug; 27(4):425-9. PubMed ID: 23421587
[TBL] [Abstract][Full Text] [Related]
15. Factors Influencing Visual Field Recovery after Transsphenoidal Resection of a Pituitary Adenoma.
Lee DK; Sung MS; Park SW
Korean J Ophthalmol; 2018 Dec; 32(6):488-496. PubMed ID: 30549473
[TBL] [Abstract][Full Text] [Related]
16. Correlation of MRI Findings With Patterns of Visual Field Loss in Patients With Pituitary Tumors.
Kane EJ; Ashton DE; Mews PJ; Reid K; Neely A; Lueck CJ
J Neuroophthalmol; 2019 Sep; 39(3):333-338. PubMed ID: 30807381
[TBL] [Abstract][Full Text] [Related]
17. Pituitary Macroadenoma and Visual Impairment: Postoperative Outcome Prediction with Contrast-Enhanced FIESTA.
Hisanaga S; Kakeda S; Yamamoto J; Watanabe K; Moriya J; Nagata T; Fujino Y; Kondo H; Nishizawa S; Korogi Y
AJNR Am J Neuroradiol; 2017 Nov; 38(11):2067-2072. PubMed ID: 28912278
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of suprasellar extension for intracranial infection after endoscopic transsphenoidal pituitary adenoma resection.
Lin M; Wang W; Tang L; Zhou Y; Li W; Xiao J; Peng Z; Xia X
World J Surg Oncol; 2023 Nov; 21(1):363. PubMed ID: 37993849
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of microperimetry and contrast sensitivity test in the diagnosis of optic chiasm compression due to pituitary adenomas.
Sarnat-Kucharczyk M; Kos-Kudła B; Kajdaniuk D; Mrukwa-Kominek E
Endokrynol Pol; 2019; 70(3):241-247. PubMed ID: 30699232
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors for the development of visual loss in patients with pituitary macroadenomas and for visual recovery after optic pathway decompression.
Monteiro ML; Zambon BK; Cunha LP
Can J Ophthalmol; 2010 Aug; 45(4):404-8. PubMed ID: 20648089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
